Hims & Hers Health Stock (NYSE:HIMS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$25.88

52W Range

$13.74 - $70.43

50D Avg

$24.57

200D Avg

$42.46

Market Cap

$5.23B

Avg Vol (3M)

$29.91M

Beta

2.61

Div Yield

-

HIMS Company Profile


Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,637

IPO Date

Sep 13, 2019

Website

HIMS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25
Non-US$133.99M
UNITED STATES$2.21B

Fiscal year ends in Dec 25 | Currency in USD

HIMS Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.35B$1.48B$872.00M
Operating Income$105.61M$61.90M$-29.45M
Net Income$128.37M$126.04M$-23.55M
EBITDA$105.61M$78.99M$-19.94M
Basic EPS$0.57$0.58$-0.11
Diluted EPS$0.51$0.53$-0.11

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 23, 26 | 5:00 PM
Q3 25Nov 03, 25 | 5:00 PM
Q2 25Aug 04, 25 | 5:00 PM

Peer Comparison


TickerCompany
PENPenumbra, Inc.
BAXBaxter International Inc.
TECHBio-Techne Corporation
MRNAModerna, Inc.
QGENQiagen N.V.
RVTYRevvity, Inc.
HQYHealthEquity, Inc.
ALGNAlign Technology, Inc.
ENSGThe Ensign Group, Inc.
BMRNBioMarin Pharmaceutical Inc.